NCT04470739

Brief Summary

COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Investigators of present study, suggested that fetuses are affected from the possible fetal inflammatory syndrome in case of maternal COVID-19. Therefore the aim of his study is to evaluate that if the cardiothymic index is affected by the maternal COVID-19 and to demonstrate any possible association of this measurement with neonatal morbidities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 12, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2020

Completed
Last Updated

July 14, 2020

Status Verified

July 1, 2020

Enrollment Period

4 months

First QC Date

July 12, 2020

Last Update Submit

July 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiothymic index

    Cardiothymic index will be measured by using the thymic shadow divided by largest diameter of mediastinum in the chest X-ray of those infants.

    4 months

Secondary Outcomes (1)

  • Immune profile

    6 months

Study Arms (2)

Infants born to COVID-19 positive mothers

ACTIVE COMPARATOR

Infants, born to COVID-19 positive mothers, will be evaluated for cardiothymic index in their first chest X-ray.

Diagnostic Test: chest x-ray

Infants born to COVID-19 negative mothers

NO INTERVENTION

Infants, born to COVID-19 negative mothers, will be evaluated for cardiothymic index in their first chest X-ray.

Interventions

chest x-rayDIAGNOSTIC_TEST

First Chest X-ray in the first 6 hours of infants

Infants born to COVID-19 positive mothers

Eligibility Criteria

AgeUp to 7 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infants born to COVID-19 positive or negative mothers
  • Accepted to participate with an informed consent
  • Infants who required to get chest X-ray within the first 6 hours

You may not qualify if:

  • Infants whose mothers' have any kind of acute or chronic systemic disease or inflammation/infection
  • Lack of an informed consent
  • Infants who did not require to get chest X-ray within the first 6 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, 34303, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

COVID-19DiGeorge Syndrome

Interventions

Diagnostic Imaging

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases22q11 Deletion SyndromeCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesLymphatic AbnormalitiesLymphatic DiseasesHemic and Lymphatic DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, InbornHypoparathyroidismParathyroid DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neonatologist

Study Record Dates

First Submitted

July 12, 2020

First Posted

July 14, 2020

Study Start

May 30, 2020

Primary Completion

September 30, 2020

Study Completion

October 30, 2020

Last Updated

July 14, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations